Momentum Stock Watch: NantHealth, Inc. (NH)

Company Profile:

NantHealth, Inc., together with its subsidiaries, operates as an evidence-based personalized healthcare company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solution, an adaptive learning system, including molecular profiling solution, software, and hardware systems infrastructure that collects, indexes, analyzes, and interprets various molecular, clinical, operational, and financial data points derived from various sources to enhance decision-making. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Recent News:

On June 20, 2018, the company announced two exciting new product launches – Provider Initiated Document Exchange and Authorization Appeals – on the nation’s leading payer-provider collaboration platform, NaviNet Open, at the 2018 AHIP Institute and Expo.

For its first quarter ended March 31, 2018, the company reported total net revenue was $22.3 million. Total 2018 first quarter net revenue prior to the impact of the new revenue recognition standard increased 14% to $21.7 million from $19.1 million in 2017 first quarter. Gross profit as presented was $11.2 million, or 50% of total net revenue.


Fundamental Analysis:

Ninestocks analyzes several different financial aspects: Growth, Profitability, solvency and efficiency.

Growth – Measures the growth of both the company’s income statement and cash flow.


Profitability – Measures the historical price movement of the stock.


Solvency – Measures the solvency of the company based on several ratios.


Efficiency – Measures the strength and historic growth of a company’s return on invested capital.



NH’s strengths can be seen in its strong growth and better efficienct compared with its peers. Its reveune has increased over recent several years. Technical indicators signal the bullish signs, as there is a bullish crossover in Stochastic oscillator, the RSI is strong in the bullish zone and the MACD is trying to cross back up. We rate NantHealth, Inc. (NH) a STRONG BUY.

About the Author

has written 12516 stories on this site.

Copyright © 2012 Nine Stocks